Worth Venture Partners, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 3.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$622,000
+59.1%
177,810
-16.9%
0.49%
+156.8%
Q2 2020$391,000
-24.8%
214,040
-35.8%
0.19%
-40.0%
Q1 2020$520,000
+1825.9%
333,389
+2532.6%
0.32%
+2361.5%
Q4 2019$27,000
-94.2%
12,664
-94.9%
0.01%
-95.1%
Q3 2019$469,000
-21.2%
250,693
+10.0%
0.27%
-18.8%
Q2 2019$595,000
+28.5%
227,943
+4.0%
0.33%
+27.5%
Q1 2019$463,000
+131.5%
219,143
+150.7%
0.26%
+70.9%
Q4 2018$200,000
+525.0%
87,400
+774.0%
0.15%
+529.2%
Q3 2018$32,00010,0000.02%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders